ABSTRACT
@#AIM:To explore the clinical efficacy of probing lacrimal passage combined with tobramycin eye drops in the treatment of congenital dacryocystitis. <p>METHODS: A total of 228 children(250 eyes)aged from 6mo-3a with congenital dacryocystitis treated in our hospital from January 2017 to June 2019 were included. They were assigned into three groups by age: 133 patients(149 eyes)aged from 6mo-1a(Group A), 62 patients(64 eyes)aged from 1-2a(Group B), and 33 patients(37 eyes)aged from 2-3a(Group C). All patients received lacrimal duct probing in surface anesthesia combined with postoperative tobramycin eye drops. <p>RESULTS: The probing cure rates of congenital dacryocystitis among there groups were 97.3%(Group A), 92.2%(Group B)and 83.8%(Group C), respectively. No adverse events reported. Through comparison of these three groups, the cure rate of children from 6mo-1a was the highest. The difference was statistically significant(<i>P</i>=0.009).<p>CONCLUSION: Lacrimal duct probing is effective in the treatment of congenital dacryocystitis, and it is safe and reliable to combine tobramycin eye drops(TOBREX)after surgery. The best time for treatment is 6mo-1a. The operation is simple, less complication, with high clinical value.
ABSTRACT
@#AIM: To analyze the clinical efficacy of neonatal dacryocystitis treated by the lacrimal passage probing(LPB)in ambulatory surgery mode during the prevalence of the COVID-19, and to provide a theoretical basis for the development and promotion of daytime operation mode of LPB in neonatal dacryocystitis.<p>METHODS: The information of 215 cases with neonatal dacryocystitis treated by LPB with ambulatory surgery mode was analyzed retrospectively, including the cure rate, the incidence of complications and adverse reactions, as well as the reasons for not arriving at the hospital after appointment.<p>RESULTS: All patients accomplish LPB surgery and daytime operation management successfully. The success rate of LPB for neonatal dacryocystitis with ambulatory surgery mode was 99.6%, with few postoperative complications and adverse reactions. The reason why the children did not arrive at the hospital after appointment was mainly due to the sickness being catching a cold, pneumonia, diarrhea and other diseases, otherwise, they had to cancel or postponed the appointment.<p>CONCLUSION: In the course of the prevalence of the COVID-19, LPB in the treatment of neonatal dacryocystitis in ambulatory surgery mode is safe, effective and feasible. It can reduce hospitalization expenses, shorten hospitalization time, and is more conducive to the prevention and control of COVID-19, which is worthy of popularization and application.
ABSTRACT
@#AIM: To investigate the clinical effect of probing lacrimal passage for congenital dacryocystitis in children. <p>METHODS: Totally 322 children(361 eyes)with congenital dacryocystitis treated in our hospital from January 2011 to December 2016 were selected and underwent lacrimal duct probing. The follow-up were taken on 1wk, 1 and 3mo after operation. <p>RESULTS: The cure rate of 322 cases(361 eyes)of congenital dacryocystitis was 99.2%(358 eyes); 3 eyes had nasolacrimal duct bony obstruction, 1 eyes had edema, 11 eyes had bleeding, and no other complications occurred. The success rate of once probing of children between 9 months to 18 months(85.0%, 204 eyes/240 eyes)was significantly higher than that of children older than 18 months(60.2%, 71 eyes/118 eyes), the difference was statistically significant(<i>χ</i><sup>2</sup>=27.387, <i>P</i><0.05). The one-time probing rate of multiple obstruction or adhesion of lacrimal duct was 4.4%(3 eyes/68 eyes), which was significantly lower than 94.1% of membranous obstruction at the lower end of lacrimal passage(273 eyes/290 eyes), the difference was statistically significant(<i>χ</i><sup>2</sup>=251.134, <i>P</i><0.05). <p>CONCLUSION: Lacrimal duct probing can be used for most congenital dacryocystitis and can relieve the symptoms of dacryocystitis effectively. The operation is simple, safe and reliable, but the therapeutic effect is closely related to the type of lacrimal passage obstruction.
ABSTRACT
AIM: To evaluate the effect of probing of lacrimal passage combining injecting of US-produced TobraDex eye ointment for the treatment of chronic dacryocystitis.METHODS: For 127 cases (129 eyes) of chronic dacryocystitis, first the pyoid secretion gathered in the lacrimal sac was dashed out, and some TobraDex was injected in the middle of the lacrimal passage once per day, repeated for several times. The lacrimal passage was probed when the secretion of lacrimal sac disappeared essentially. The lacrimal passage and immit TobraDex eye ointment was used once every two days, repeated for 3-4 times.RESULTS: In 126 cases (128 eyes) the lacrimal passage was dredged. Only one case (1 eye) the youthful patient did not recover for the opening ectopia of lacrimonasal duct.During the 3mo-1a random visit the chronic dacryocystitis did not recrudesce in the cases of lacrimal passage dredging.CONCLUSION: It is simple and safe to use the probing of lacrimal passage combining injecting of US-produced TobraDex eye ointment to treat the chronic dacryocystitis. This method has good curative effects and can keep the normal physiological structure of lacrimal passage. It does not need any expensive medical equipment and cost less, therefore is advisable for patients.